I dont think this smells at all. The most logical answer is usually the correct one and they are backing themselves that that the drug works and will be approved. Surely Acardia would have wanted the ROW rights so specifically carving that out only compounds my thought that the Board fully expects this to be approved and if that the case it been set-up perfectly.
- Forums
- ASX - By Stock
- NEU
- Bell Porter Review
Bell Porter Review, page-68
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.39 |
Change
0.000(0.00%) |
Mkt cap ! $2.478B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6 | $20.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.44 | 108 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 327 | 20.410 |
3 | 258 | 20.350 |
2 | 18 | 20.030 |
2 | 14 | 19.980 |
1 | 85 | 19.650 |
Price($) | Vol. | No. |
---|---|---|
18.440 | 72 | 2 |
18.820 | 12 | 2 |
19.300 | 1274 | 2 |
19.400 | 80 | 1 |
19.410 | 80 | 1 |
Last trade - 09.56am 31/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online